gdufa ii – review timelines (14of27) generic drugs forum 2018
Published 4 years ago • 832 plays • Length 17:19Download video MP4
Download video MP3
Similar videos
-
17:29
gdufa ii user fees: update on year one (21of27) generic drugs forum 2018
-
14:56
drug substance review - anda (22/28) generic drugs forum 2017
-
24:07
filing review basics – examples of refuse-to-receive (rtr) (15of27) generic drugs forum 2018
-
15:00
filing review – do’s and don’ts (14/28) generic drugs forum 2017
-
23:06
gdufa ii pre-anda program meetings: advice for success (10of27) generic drugs forum 2018
-
13:36
application communications: rbpm communication with industry throughout the iqa (24of27) gdf 2018
-
52:19
facility readiness: gmps, quality assessments, and compliance trends (15of16) gdf 2020
-
1:13:54
goodfellow unit webinar: dulaglutide 12 months on
-
20:18
drug substance quality assessment: best practices (23of27) generic drugs forum 2018
-
20:14
generic drug product quality assessment (22of27) generic drugs forum 2018
-
20:47
generic drug product quality review (23/28) generic drugs forum 2017
-
16:56
orange book: 101 an overview (11of27) generic drugs forum 2018
-
22:08
timeline for the drug master review process
-
37:26
pharmaceutical quality update by dr. michael kopcha (2of27) generic drugs forum april 2018
-
31:03
anda performance/operations update (3of27) generic drugs forum april 2018
-
38:23
anda program performance review and tips (8of16) generic drugs forum 2020
-
16:56
global generic drug landscape
-
19:43
gdufa ii (9/28) generic drugs forum 2017
-
25:50
integrated process and facilities assessment (26of27) generic drugs forum 2018
-
17:27
pre-anda review: office of pharmaceutical quality (opq) (4of39) complex generics 2018
-
31:44
keynote – office of generic drugs (1/28) generic drugs forum 2017
-
15:39
office of generic drugs keynote (1of39) complex generics 2018